Strategic plan progress report. Research: Driving the development of innovative and precise drugs, medical devices, and diagnostic tests. Flu treatments; Tackling antimalarial resistance; Attacking hard targets; Plotting cell maps; Safer opioid pain killer; Cellular construction; New products through bioengineering; Regulatory science leadership; Tobacco burden in vulnerable populations; Economics of disease; Precision medicine. Education: Preparing leaders who think critically, work across fields, and lead in rapidly changing marketplaces. PharmD curriculum for 2018 and beyond; Transforming teaching; Coursework in regulatory science and translational medicine; Interdisciplinary exposure. Patient Care: Reframing how medication needs of patients are met. Importance of health information exchange; Outcomes research; Treating patients with more precise medications. People: Supporting our agents of change—our faculty, staff, and alumni. New faculty leaders; Housing and child care; Staff support and engagement; PharmD admissions; Unconscious bias. Framework for Success: Ensuring the School has the framework needed to excel. Support for enabling technology centers; Philanthropic support; Online presence.

September 4, 2017

Janet Wells

First page
Previous page
…
Page 9
Page 10
Page 11
Page 12
Current page 13
Page 14
Page 15
Page 16
Page 17
…
Next page
Last page